Reposted from WuXi STA

(2023年)

WuXi STA became the preferred partner of Coherent Biopharma to accelerate their diverse pipeline of Peptide Drug Conjugate (PDC) products. PDC drugs have broad applications but face many development challenges for the peptide, high potency payload, and conjugation. WuXi STA’s industry-leading CMC platform provides a one-stop solution for PDC drug development and manufacturing, from API (including peptide, payload, and the conjugate) to formulation development and manufacturing.

Learn more about our peptide and PDC capability:https://peptide.wuxiapptec.com/

コメント